Immatics NV (IMTX)
9.96
+0.06
(+0.61%)
USD |
NASDAQ |
Feb 13, 14:13
Immatics Free Cash Flow : -205.18M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CureVac NV | -144.00M |
| Bayer AG | 2.692B |
| MediGene AG | -- |
| InflaRx NV | -47.11M |
| BioNTech SE | -588.89M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -54.74M |
| Cash from Investing (Quarterly) | 147.12M |
| Cash from Financing (Quarterly) | -0.9078M |
| Free Cash Flow Per Share (Quarterly) | -0.4621 |
| Free Cash Flow to Equity (Quarterly) | -55.32M |
| Free Cash Flow to Firm (Quarterly) | -55.90M |
| Free Cash Flow Yield | -16.95% |